AI Article Synopsis
- Ultrasonic-assisted extraction was used to isolate ACE-inhibiting peptides from walnut protein isolate, with optimal conditions set at 15 minutes and 400 W.
- Two new peptides, Tyr-Ile-Gln (YIQ) and Ile-Tyr-Gln (IYQ), were identified, alongside a novel synthetic peptide, Ile-Lys-Gln (IKQ), which showed enhanced ACE-inhibiting activity.
- The study suggests these peptides could be non-toxic and beneficial for nitric oxide production, highlighting the potential of ultrasonicated walnut protein as a source for developing functional food ingredients.
Article Abstract
Angiotensin I-converting enzyme (ACE)-inhibiting peptides were isolated from walnut protein isolate (WPI) using ultrasound-assisted extraction. This study aimed to assess the impact of ultrasonic pretreatment on the physicochemical properties of WPI. The optimal extraction conditions for WPI were determined as a 15-min ultrasonic treatment at 400 W. Subsequently, the hydrolysate exhibiting the highest in vitro ACE-inhibiting activity underwent further processing and separation steps, including ultrafiltration, ion exchange chromatography, liquid chromatography-tandem mass spectrometry, ADMET screening, and molecular docking. As a result of this comprehensive process, two previously unidentified ACE-inhibiting peptides, namely Tyr-Ile-Gln (YIQ) and Ile-Tyr-Gln (IYQ), were identified. In addition, a novel peptide, Ile-Lys-Gln (IKQ), was synthesized, demonstrating superior ACE-inhibiting activity and temperature stability. In silico analysis estimated an in vivo utilization rate of 21.7% for IKQ. These peptides were observed to inhibit ACE through an anti-competitive mechanism, with molecular docking simulations suggesting an interaction mechanism involving hydrogen bonding. Notably, both IYQ and IKQ peptides exhibited no discernible toxicity to HUVECs cells and promoted nitric oxide (NO) generation. These findings underscore the potential of ultrasonicated WPI in the separation of ACE-inhibiting peptides and their utility in the development of novel ACE inhibitors for functional food applications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11130-023-01122-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Integrated network pharmacology and experimental validation to explore the mechanisms of Coregonus peled-derived myosin ACE-inhibiting peptides for the treatment of hypertension.
Int J Biol Macromol
January 2025
School of Food Science and Technology, Shihezi University, Shihezi 832003, Xinjiang, China; Key Laboratory of Agricultural Product Processing and Quality Control of Specialty(Co-construction by Ministry and Province), School of Food Science and Technology, Shihezi University, Shihezi, Xinjiang 832003, China; Key Laboratory for Food Nutrition and Safety Control of Xinjiang Production and Construction Corps, School of Food Science and Technology, Shihezi University, Shihezi, Xinjiang 832003, China. Electronic address:
Article Synopsis
- The study focused on extracting ACE inhibitory peptides from Coregonus peled, a fish rich in protein and bioactive peptides.
- Six potent peptides were screened, with LCYPR demonstrating the highest activity in inhibiting ACE and potential applications for hypertension treatment.
- The research identified critical biological targets and pathways associated with LCYPR, offering insights for developing new antihypertensive therapies and functional foods from this fish species.
Research on the Synergistic Inhibition of Angiotensin-Converting Enzyme (ACE) by the Gastrointestinal Digestion Products of the ACE Inhibitory Peptide FPPDVA.
J Agric Food Chem
November 2024
School of Materials Science and Engineering, Shandong University, Jinan, Shandong 250061, China.
To gain a deeper understanding of the ACE inhibition effect, the inhibitory effect of ACE-inhibiting peptide (ACEIP) FPPDVA's digestive products on ACE was further investigated. Two novel peptides, PD (IC = 161.1 ± 1.
View Article and Find Full Text PDFPeptidomics-based study of antihypertensive activity: discovery of novel ACE inhibiting peptides from peanut yogurt.
Food Funct
June 2024
College of Food Science, South China Agricultural University, Guangzhou 510642, China.
Studies have confirmed that yogurt has the activity of regulating blood pressure because it is rich in probiotic-fermented food-derived active peptides. There are also studies on angiotensin-converting enzyme inhibition (ACEI) peptide milk, but the bioactive molecules in it are still unclear. Therefore, in this study, we developed a peanut yogurt with ACEI activity, analyzed 1877 differential peptides and their antihypertensive pathways before and after fermentation using peptidomics, and identified three peptides (FLPYPY, QPPPSPPPFL and APFPEVFGK) with potential antihypertensive activity using molecular docking and chemical synthesis techniques.
View Article and Find Full Text PDFPreparation, identification, and molecular docking of novel angiotensin-converting enzyme inhibitory peptides derived from rice-based distillers' spent cakes.
J Sci Food Agric
August 2024
Baijiu Fermentation Technology Research Center of Jiangnan University-Kweichow Zhen Distillery Co. Ltd, Wuxi, China.
Background: Rice-based distillers' spent cake (RDSC), a by-product of the Chinese liquor (Baijiu) industry, is a potential source of angiotensin-converting enzyme (ACE) inhibitory peptide. Since ACE plays a crucial role in controlling hypertension, inhibition of ACE has been widely emphasized. The ACE inhibitory active peptide derived from by-products of food has been recognized as a safer and cheaper inhibitor.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!